Cervical cancer screening protocols may need fundamental revision for HIV-positive women, who face substantially different risk patterns than the general population. This reality affects millions of women globally, as HIV infection creates a persistent vulnerability to aggressive cervical disease that current screening guidelines may inadequately address. A comprehensive meta-analysis spanning seven countries examined age-specific cervical cancer and precancer rates among HIV-positive women to inform updated World Health Organization screening recommendations. The research synthesized data from multiple studies covering 2012-2019, focusing on histopathologically confirmed disease outcomes across different age groups. The analysis revealed that HIV-positive women develop cervical precancer and cancer at rates that differ significantly from HIV-negative populations, with implications for both screening initiation age and interval timing. The study employed individual patient data meta-analysis techniques to provide more granular insights than previous summary-level reviews. This research addresses three critical clinical questions: the optimal age to begin cervical cancer screening in HIV-positive women, appropriate intervals between negative screens, and post-treatment surveillance schedules. The findings represent a significant step toward evidence-based screening protocols specifically tailored for HIV-positive populations. However, the observational nature of the included studies limits causal inference, and screening program effectiveness depends heavily on healthcare system capacity and patient adherence. The research highlights how HIV fundamentally alters cervical cancer epidemiology, potentially requiring age-specific approaches that diverge from standard population screening guidelines. This work could influence global screening policies affecting millions of HIV-positive women worldwide.